With CEPI support, LenioBio is using its plant-based AliCE® tech to rapidly produce proteins needed for protein-based vaccines, potentially cutting timelines from months to days.
Watch the video below to learn more ⬇️ bit.ly/4n0reoN
With CEPI support, LenioBio is using its plant-based AliCE® tech to rapidly produce proteins needed for protein-based vaccines, potentially cutting timelines from months to days.
Watch the video below to learn more ⬇️ bit.ly/4n0reoN
Alongside our regular content, this month features our new Innovations for Impact series, kicking off with stories on Lassa fever and Rift Valley fever, spotlighting some of the researchers working to reduce the risks posed by these diseases ⬇️ bit.ly/4d57trJ
Alongside our regular content, this month features our new Innovations for Impact series, kicking off with stories on Lassa fever and Rift Valley fever, spotlighting some of the researchers working to reduce the risks posed by these diseases ⬇️ bit.ly/4d57trJ
The CEPI and @ec.europa.eu supported global project is led by @imperialcollegeldn.bsky.social: www.imperial.ac.uk/Stories/the-...
The CEPI and @ec.europa.eu supported global project is led by @imperialcollegeldn.bsky.social: www.imperial.ac.uk/Stories/the-...
Find out how new Lassa vaccine trials in West Africa are boosting global viral defences ➡️ cepi.net/how-new-vacc...
Available wherever you listen to podcasts. Transcript: bit.ly/4bLdDNb
Available wherever you listen to podcasts. Transcript: bit.ly/4bLdDNb